Talecris shareholders to vote on merger with Grifols

02/14/2011 | MedCityNews.com

Talecris Biotherapeutics shareholders today will vote on whether to approve a merger with Spanish firm Grifols. Grifols shareholders already have approved the move and Talecris shareholders are expected to do the same. The Federal Trade Commission is set to issue its decision on the merger by March.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC